<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33399906</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex.</ArticleTitle><Pagination><StartPage>5272</StartPage><EndPage>5280</EndPage><MedlinePgn>5272-5280</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-020-07547-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of our study was to investigate whether the magnetic susceptibility varies according to the amyotrophic lateral sclerosis (ALS) phenotypes based on the predominance of upper motor neuron (UMN)/lower motor neuron (LMN) impairment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively collected imaging and clinical data of 47 ALS patients (12 with UMN predominance (UMN-ALS), 16 with LMN predominance (LMN-ALS), and 19 with no clinically defined predominance (Np-ALS)). We further enrolled 23 healthy controls (HC) and 15 ALS mimics (ALS-Mim). These participants underwent brain 3-T magnetic resonance imaging (3-T MRI) with T1-weighted and gradient-echo multi-echo sequences. Automatic segmentation and quantitative susceptibility mapping (QSM) were performed. The skewness of the susceptibility values in the precentral cortex (SuscSKEW) was automatically computed, compared among the groups, and correlated to the clinical variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Kruskal-Wallis test showed significant differences in terms of SuscSKEW among groups (&#x3c7;<sup>2</sup>(3) = 24.2, p &lt; 0.001), and pairwise tests showed that SuscSKEW was higher in UMN-ALS compared to those in LMN-ALS (p &lt; 0.001), HC (p &lt; 0.001), Np-ALS (p = 0.012), and ALS-Mim (p &lt; 0.001). SuscSKEW was highly correlated with the Penn UMN score (Spearman's rho 0.612, p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study demonstrates that the clinical ALS phenotypes based on UMN/LMN sign predominance significantly differ in terms of magnetic susceptibility properties of the precentral cortex. Combined MRI-histopathology investigations are strongly encouraged to confirm whether this evidence is due to iron overload in UMN-ALS, unlike in LMN-ALS.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">&#x2022; Magnetic susceptibility in the precentral cortex reflects the prevalence of UMN/LMN impairment in the clinical ALS phenotypes. &#x2022; The degree of UMN/LMN impairment might be well described by the automatically derived measure of SuscSKEW in the precentral cortex. &#x2022; Increased SuscSKEW in the precentral cortex is more relevant in UMN-ALS patients compared to those in Np-ALS and LMN-ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Conte</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Contarino</LastName><ForeName>Valeria Elisa</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casale</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6286-7537</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy. casale.silvia88@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbaraini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, ASST Santi Paolo e Carlo, San Carlo Borromeo Hospital, Via Pio II 3, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scola</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trogu</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siggillino</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinnante</LastName><ForeName>Claudia Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caschera</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Russo</LastName><ForeName>Francesco Maria</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triulzi</LastName><ForeName>Fabio Maria</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Motor cortex</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33399906</ArticleId><ArticleId IdType="doi">10.1007/s00330-020-07547-5</ArticleId><ArticleId IdType="pii">10.1007/s00330-020-07547-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ludolph A, Drory V, Hardiman O et al (2015) A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener 16:291&#x2013;292. https://doi.org/10.3109/21678421.2015.1049183</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, van den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15:1182&#x2013;1194</Citation></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L et al (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin 12:965&#x2013;969. https://doi.org/10.1016/j.nicl.2016.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.04.011</ArticleId><ArticleId IdType="pubmed">27995062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P et al (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 7:e35241. https://doi.org/10.1371/journal.pone.0035241</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y et al (2015) Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 25:443&#x2013;451</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12127</ArticleId></ArticleIdList></Reference><Reference><Citation>Contarino VE, Conte G, Morelli C et al (2020) Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: a fully automatic investigation of the magnetic susceptibility in the precentral cortex. Eur J Radiol 124:108815. https://doi.org/10.1016/j.ejrad.2020.108815</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.108815</ArticleId><ArticleId IdType="pubmed">31945675</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer AD, Liu T, Gupta A et al (2015) Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol 204:1086&#x2013;1092. https://doi.org/10.2214/AJR.14.13459</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.14.13459</ArticleId><ArticleId IdType="pubmed">25905946</ArticleId><ArticleId IdType="pmc">4889122</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A et al (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119:497&#x2013;503. https://doi.org/10.1016/j.clinph.2007.09.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC (2016) Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clin Neurophysiol 127:2643&#x2013;2660. https://doi.org/10.1016/j.clinph.2016.04.025</Citation></Reference><Reference><Citation>V&#xe1;zquez-Costa JF, Maz&#xf3;n M, Carreres-Polo J et al (2018) Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis. Acta Neurol Scand 137:262&#x2013;271. https://doi.org/10.1111/ane.12863</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12863</ArticleId><ArticleId IdType="pubmed">29082510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13&#x2013;21. https://doi.org/10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Talbot K (2013) Mimics and chameleons in motor neurone disease. Pract Neurol 13:153&#x2013;164. https://doi.org/10.1136/practneurol-2013-000557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2013-000557</ArticleId><ArticleId IdType="pubmed">23616620</ArticleId><ArticleId IdType="pmc">3664389</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Li W, Tong KA, Yeom KW, Kuzminski S (2015) Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 42:23&#x2013;41. https://doi.org/10.1002/jmri.24768</Citation></Reference><Reference><Citation>Fischl B (2012) FreeSurfer. Neuroimage 62:774&#x2013;781. https://doi.org/10.1016/j.neuroimage.2012.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.01.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Quade D (1967) Rank analysis of covariance. J Am Stat Assoc 62:1187&#x2013;1200</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1967.10500925</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Stein B, Partain M et al (2011) Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol 121:509&#x2013;517. https://doi.org/10.1007/s00401-011-0797-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0797-z</ArticleId><ArticleId IdType="pubmed">21225272</ArticleId><ArticleId IdType="pmc">3125638</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xed; MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G (2003) Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61:365&#x2013;374. https://doi.org/10.1016/s0361-9230(03)00179-5</Citation></Reference><Reference><Citation>Wang Y, Spincemaille P, Liu Z et al (2017) Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care. J Magn Reson Imaging 46:951&#x2013;971. https://doi.org/10.1002/jmri.25693</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.25693</ArticleId><ArticleId IdType="pubmed">5592126</ArticleId><ArticleId IdType="pmc">5592126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheykhansari S, Kozielski K, Bill J et al (2018) Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death Dis 9:348. https://doi.org/10.1038/s41419-018-0379-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0379-2</ArticleId><ArticleId IdType="pubmed">29497049</ArticleId><ArticleId IdType="pmc">5832817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M et al (2003) Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 60:1252&#x2013;1258. https://doi.org/10.1212/01.wnl.0000058901.75728.4e</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000058901.75728.4e</ArticleId><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell B, Oppenheimer DR, Hughes JT (1970) The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 33:338&#x2013;357. https://doi.org/10.1136/jnnp.33.3.338</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.33.3.338</ArticleId><ArticleId IdType="pubmed">5431724</ArticleId><ArticleId IdType="pmc">493478</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan C-F, Hoshi Y et al (2009) Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol 117:45&#x2013;53. https://doi.org/10.1007/s00401-008-0443-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0443-6</ArticleId><ArticleId IdType="pubmed">18923836</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y, Atsuta N, Yoshida M et al (2014) Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open 4:e005213. https://doi.org/10.1136/bmjopen-2014-005213</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005213</ArticleId><ArticleId IdType="pubmed">24833696</ArticleId><ArticleId IdType="pmc">4025414</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Agosta F, Ferraro PM et al (2016) Brain MR imaging in patients with lower motor neuron-predominant disease. Radiology 280:545&#x2013;556. https://doi.org/10.1148/radiol.2016151846</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2016151846</ArticleId><ArticleId IdType="pubmed">26963576</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S (2009) Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29:610&#x2013;619</Citation></Reference><Reference><Citation>Golko-Perez S, Amit T, Bar-Am, Youdim MBH, Weinreb O (2017) A novel iron chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1G93A ALS mice. Neurotox Res 31:230&#x2013;244</Citation></Reference><Reference><Citation>Moreau C, Danel V, Devedjian JC et al (2018) Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?&#xa9; Caroline Moreau et al 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License ( http://creativecommons.org/licenses/by/4.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Antioxid Redox Signal 29:742&#x2013;748</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>